ArriVent BioPharma Inc. C...

NASDAQ: AVBP · Real-Time Price · USD
19.54
0.92 (4.94%)
At close: Aug 15, 2025, 3:59 PM
19.58
0.20%
After-hours: Aug 15, 2025, 05:41 PM EDT

ArriVent BioPharma Common Stock Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-80.49M -69.33M -36.91M -51.61M
Depreciation & Amortization
n/a n/a n/a n/a
Stock-Based Compensation
3.21M 895.00 424K 66.67K
Other Working Capital
7.82M 11.22M -9.95M -4.23M
Other Non-Cash Items
n/a 1.38K -2.38M 42.67M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
7.07M 12.6M -7.15M -3.94M
Operating Cash Flow
-70.21M -55.84M -43.63M -12.59M
Capital Expenditures
n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
-194.16M -25M n/a n/a
Sales Maturities Of Investments
1.7M 25M n/a n/a
Other Investing Acitivies
n/a n/a n/a -40M
Investing Cash Flow
-192.47M n/a n/a -40M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
631K 42.86K 15K 119.82M
Financial Cash Flow
186.58M 42.86M 169.72M 89.87M
Net Cash Flow
-76.1M -12.98M 126.09M 37.28M
Free Cash Flow
-70.21M -55.84M -43.63M -12.59M